USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: TOMEGAVAX, INC.
Address: 505 NW 185TH AVE
BEAVERTON, OR 97006-3448
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,835.00 1
STTR Phase I $573,060.00 1

Award List:

Spread-deficient HCMV-vectored vaccines

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Emily E. Marshall – 503-341-1697
Award Amount: $299,835.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this project is to establish human cytomegalovirus (HCMV) as a new human vaccine vector platform. In non-human primate models, CMV-vectored vaccines have shown unprecedented protection against immunodeficiency viruses and similar vaccines are… More

A Synthetic Human Cytomegalovirus Vaccine Platform

Award Year / Program / Phase: 2013 / STTR / Phase I
Agency: HHS
Research Institution: OREGON HEALTH AND SCIENCE UNIVERSITY
Principal Investigator: Sanjay Vashee – 301-795-7254
Award Amount: $573,060.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The goal of this project is to synthesize, based on genomic sequence information, a human cytomegalovirus (HCMV) strain with demonstrated ability to establish persistent infection in sero-positive individuals. The resulting synthetic product will form the basis… More